Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records β€” linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review claims


     Quick Explanation



    Author review β€” Fan Wu

    Summary: Fan Wu is an early-career researcher with a small publication set (n=5), modest citation impact (total citations β‰ˆ59) and an h-index β‰ˆ3; recent work spans translational cancer biology (EGFL9 in HCC) and design/biomimetics (HBBES for Chaozhou woodcarving) showing interdisciplinary scope but limited external validation so far




     Long Explanation



    Author Review β€” Fan Wu

    Visual summary first β€” metrics and paper types (unique divs + graphs below).

    Evidence-based critique (visual-first)

    • Productivity & impact: Small corpus (5 papers) with 59 total citations and h-index β‰ˆ3 β€” typical of an early-career investigator or clinician–scientist contributor rather than a field leader; metrics indicate limited external uptake so far (see metric plot above).
    • Scope & interdisciplinarity: Work spans molecular oncology (circRNA/lncRNA; EGFL9 biomarker), clinical case reports, and a biomimetics/design methods paper (HBBES), suggesting methodological breadth and ability to publish in both biomedical and design journals

    Strengths (evidence-linked)

    • Demonstrated capacity to lead and report multi-method studies combining experiments, omics, and in vivo models (EGFL9 paper includes transcriptomics/proteomics/metabolomics integration and animal validation)
    • Interdisciplinary reach: able to publish in design/biomimetics venues and biomedical journals β€” useful for translational projects bridging cultural heritage and engineering (HBBES)

    Weaknesses, blindspots & risks

    1. Limited sample sizes and external validation: EGFL9 study uses modest clinical n (β‰ˆ40 tissue pairs; serum nβ‰ˆ30) and in vivo mouse models but lacks large independent cohorts or public raw data deposition β€” reduces generalizability and reproducibility
    2. Methodological limitations in non-biomedical work: HBBES relies on 2D photographic inputs and expert/public panels (AHP/FCE) β€” authors acknowledge that mechanical/3D validation (FEA, VR) is missing; claims about translating tacit craft knowledge to engineering need quantitative structural corroboration
    3. Sparse data sharing & reproducibility friction: At least one translational paper lists data availability only by contacting the corresponding author; raw multi-omics deposition would strengthen reproducibility (EGFL9: availability on request)
    4. Small citation footprint: Total citations β‰ˆ59 reflect modest external uptake β€” not necessarily a quality issue but indicates work has not yet influenced large literatures; growth potential exists if follow-up validation and data sharing occur.

    Concrete recommendations (how Fan Wu can raise scientific strength)

    • Deposit raw datasets (RNA-seq, proteomics, metabolomics) and processed code to public repositories (GEO/PRIDE/MetaboLights + GitHub) with DOIs to enable external validation.
    • Replicate key findings in independent cohorts or multi-center samples (for EGFL9: validate serum biomarker performance in separate HCC cohorts and provide ROC/AUC with confidence intervals).
    • For HBBES: acquire 3D scans and run FEA/mechanical validation of structural claims and provide open 3D models to support engineering translation.
    • Increase clarity on sample sizes, randomization/blinding in in vivo experiments, and annotate effect sizes with confidence intervals rather than p-values alone.

    What would disprove the main claims?

    • For EGFL9: failure to replicate EGFL9 upregulation or prognostic/functional effects in independent patient cohorts or multi-center validations would falsify biomarker/driver claims
    • For HBBES: 3D structural/mechanical testing (FEA) showing that morphological analogy and light modulation do not yield functional mechanical advantages would invalidate core engineering claims in HBBES

    Selected primary evidence (direct links)

    Note: This review is evidence-focused, citing Fan Wu’s own recent papers; the author-level metrics used were provided by the user (paper count=5, citations=59, h-index=3). Comments prioritize reproducibility, cohort validation, and open data to increase scientific influence.


    Feedback:    

    Updated: February 14, 2026

     BGPT Author Review



    Scientific Quality

    40%

    Fan Wu demonstrates ability to design multi-method studies and publish across domains (oncology, biomimetics), but current scientific impact is limited by small corpus, modest citation traction, limited public data deposition, and restricted external validation; these facts lower the score despite methodological competence and clear potential.



    Communication Quality

    60%

    Writing and reporting appear adequate β€” methods are described and limitations acknowledged (e.g., HBBES notes 2D limitations; EGFL9 provides sample counts and methods), but clearer public data links, more transparent methods (raw code/data), and more robust effect-size reporting would improve clarity and external reproducibility.



    Author Novelty

    60%

    Work contains novel elements (HBBES framework applying AHP+FCE to craft biomimetics; EGFL9 as a proposed HCC biomarker with multi-omics), but novelty is moderate because findings require independent replication and broader translation to become high-impact.



    Scientific Rigor

    50%

    Experiments show standard molecular and in vivo approaches and multi-omics integration, indicating technical competence; however, limited sample sizes, single-cohort designs, and absence of public raw-data deposition reduce reproducible rigor and transparency.

     Top Data Sources ExportMCP



     Analysis Wizard



    Preparing reproducible analysis pipelines to re-process EGFL9 RNA-seq/proteomics data and compute differential expression, pathway enrichment, and predictive ROC using the study's reported sample groups (requires raw files).



     Hypothesis Graveyard



    That high citation counts are necessary to identify scientific quality β€” Fan Wu’s low citation counts reflect early stage/career rather than poor science; however, reproducibility and deposit practices remain decisive.


    That interdisciplinary publications automatically translate to translational impact β€” without mechanical/clinical validation, interdisciplinary novelty may remain locally interesting but not broadly adopted.

     Science Art


    Author Review: Fan Wu Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT